Streetbeat News

Stock Prices

BTCUSD

FTTUSD

The value of a cryptocurrency named HairyPlotterFTX (FTX) surged by 510% following the guilty verdict of FTX founder, Sam Bankman-Fried, on charges of defrauding customers and lenders. Meanwhile, FTX's native token FTT (CRYPTO: FTT) is down 1.20%. Bankman-Fried could face several decades in prison, with sentencing set for March 28, 2024.

Portfolio Pulse from Mehab Qureshi

November 03, 2023 | 5:54 am

FXI

China's Caixin Services Purchasing Managers Index (PMI) for October was reported at 50.4, lower than the estimated 51.2 and slightly higher than the previous 50.2.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 5:00 am

BTCUSD

Block Inc (NASDAQ:SQ) reported a 37.5% growth in Bitcoin revenue to $2.42 billion in Q3, surpassing analyst expectations. The company's gross profit from Bitcoin rose to $44 million, up from $36 million the previous year. The value of Bitcoin holdings in its corporate treasury was $216 million, exceeding their book value by $114 million. Block's total revenue grew 24% YoY to $5.62 billion, with Bitcoin revenue accounting for 43% of the total. The company's share price surged in after-hours trading.

Portfolio Pulse from Mehab Qureshi

November 03, 2023 | 4:54 am

DOGEUSD

Sam Bankman-Fried, the founder of FTX, has been found guilty of seven criminal counts, including wire fraud and conspiracy to commit securities fraud. Following the verdict, Dogecoin co-creator Billy Markus criticized Bankman-Fried for his actions. The price of Dogecoin (DOGE) has fallen by 3.76% in the last 24 hours.

Portfolio Pulse from Mehab Qureshi

November 03, 2023 | 3:05 am

BTCUSD

DOGEUSD

ETHUSD

Major cryptocurrencies including Bitcoin, Ethereum, and Dogecoin experienced a drop after Sam Bankman-Fried, founder and former CEO of FTX, was found guilty of defrauding his customers and lenders. Despite this, analysts predict an 'explosive' phase for Bitcoin as long-term indicators turn bullish. Meanwhile, the S&P 500 and Nasdaq Composite saw gains as Treasury yields decreased, and labor market data showed easing inflation and a slowdown.

Portfolio Pulse from Mehab Qureshi

November 03, 2023 | 2:32 am

DKNG

IONS

MRNA

NVDA

Ark Invest, led by Cathie Wood, has made significant changes to its holdings, selling a large portion of DraftKings Inc (DKNG) shares and buying Moderna Inc (MRNA) stock. This comes despite DraftKings' positive earnings report and Moderna's current challenges with vaccine demand. Other trades include selling shares of NVIDIA Corp (NVDA), Ionis Pharmaceuticals Inc (IONS), and General Motors Co (GM).

Portfolio Pulse from Benzinga Neuro

November 03, 2023 | 2:27 am

AAPL

CVNA

DKNG

PLTR

US stocks saw an uptick as trading closed on Thursday. Apple Inc., DraftKings Inc., Block Inc., Carvana Co., and Palantir Technologies Inc. were the top stocks that gained the attention of retail traders and investors. Apple's Q4 results surpassed estimates with a notable increase in Services revenue. DraftKings' Q3 earnings report showed a revenue beat and an EPS outperformance. Block's earnings preview highlighted the company's solid margins and cash position. Carvana's Q3 earnings report revealed a significant increase in gross profit per vehicle. Palantir's strong Q3 performance was driven by growth in both commercial and government sectors.

Portfolio Pulse from Benzinga Neuro

November 03, 2023 | 1:53 am

PBYI

Puma Biotechnology has projected its FY23 revenue to be between $206M-$209M, which is lower than the estimated $236.23M.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 10:01 pm

BITO

EETH

ETHUSD

ProShares is launching the ProShares Short Ether Strategy (SETH), an ETF that delivers the inverse of the daily performance of the Standard & Poor's CME Ether Futures Index. The ETF is designed to appeal to bearish investors and is tied to futures contracts on Ethereum. The ETF will trade on the NYSE's Arca. ProShares has previously launched three Ethereum ETFs, including the ProShares Ether Strategy ETF (EETH), which averaged around 8,660 shares daily in its first month.

Portfolio Pulse from Khyathi Dalal

November 02, 2023 | 10:01 pm

PBYI

Puma Biotechnology has projected its Q4 2023 product revenue to be between $56M-$59M, which is significantly lower than the estimated $71.45M.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 10:00 pm